IQVIA Holdings Inc. (IQV) Income Statement

NYSE: IQVRevenue, profits, margins and EPS over 10 years.

IQV 2025 at a glance

Fiscal year ended December 31, 2025 · U.S. dollars
Revenue+5.9%
$16.31B
2025 · hover or tap a bar for each year
2016: $6.82B (+18.8%)2017: $9.70B (+42.4%)2018: $10.41B (+7.3%)2019: $11.09B (+6.5%)2020: $11.36B (+2.4%)2021: $13.87B (+22.1%)2022: $14.41B (+3.9%)2023: $14.98B (+4.0%)2024: $15.40B (+2.8%)2025: $16.31B (+5.9%)
20162025
Gross profit+1.0%
$5.43B
2025 · hover or tap a bar for each year
2016: $2.07B (+27.5%)2017: $3.40B (+64.5%)2018: $3.67B (+7.8%)2019: $3.79B (+3.3%)2020: $3.86B (+1.9%)2021: $4.64B (+20.3%)2022: $5.03B (+8.3%)2023: $5.24B (+4.2%)2024: $5.38B (+2.6%)2025: $5.43B (+1.0%)
20162025
Operating income−0.9%
$2.18B
2025 · hover or tap a bar for each year
2016: $642.0M (−0.7%)2017: $719.0M (+12.0%)2018: $741.0M (+3.1%)2019: $777.0M (+4.9%)2020: $731.0M (−5.9%)2021: $1.39B (+90.6%)2022: $1.80B (+29.1%)2023: $1.98B (+9.9%)2024: $2.20B (+11.4%)2025: $2.18B (−0.9%)
20162025
Net income−0.9%
$1.36B
2025 · hover or tap a bar for each year
2016: $115.0M (−70.3%)2017: $1.31B (+1,038.3%)2018: $259.0M (−80.2%)2019: $191.0M (−26.3%)2020: $279.0M (+46.1%)2021: $966.0M (+246.2%)2022: $1.09B (+12.9%)2023: $1.36B (+24.5%)2024: $1.37B (+1.1%)2025: $1.36B (−0.9%)
20162025
EPS (diluted)+7.1%
$11.93
2025 · hover or tap a bar for each year
2016: $3.28 (−1.8%)2017: $4.69 (+43.0%)2018: $5.55 (+18.3%)2019: $6.40 (+15.3%)2020: $6.42 (+0.3%)2021: $9.03 (+40.7%)2022: $10.17 (+12.6%)2023: $10.21 (+0.4%)2024: $11.14 (+9.1%)2025: $11.93 (+7.1%)
20162025
Net profit margin−0.6 pts
8.3%
2025 · hover or tap a point for each year
2016: 1.7% (−5.1 pts)2017: 13.5% (+11.8 pts)2018: 2.5% (−11.0 pts)2019: 1.7% (−0.8 pts)2020: 2.5% (+0.7 pts)2021: 7.0% (+4.5 pts)2022: 7.6% (+0.6 pts)2023: 9.1% (+1.5 pts)2024: 8.9% (−0.2 pts)2025: 8.3% (−0.6 pts)
20162025

IQV revenue and net income

RevenueNet incomeNet margin (right axis)

Where IQV's revenue goes

2025
Revenue
$16.31B100.0%
Cost of revenue
−$10.88B−66.7%
Gross profit
$5.43B33.3%
Sales, general & admin
−$2.00B−12.3%
Other operating expenses
−$1.25B−7.7%
Operating income
$2.18B13.4%
Interest & other expense
−$569.0M−3.5%
Income taxes
−$252.0M−1.5%
Net income
$1.36B8.3%

Each bar shows an amount and its share of revenue. IQV kept 8.3% of revenue as net income.

IQV profit margins

GrossOperatingNet

IQV growth rates

to 2025
1 year3 years5 years10 years
Revenue+5.9%+4.2%+7.5%+11.0%
Gross profit+1.0%+2.6%+7.1%+12.9%
Operating income−0.9%+6.6%+24.4%+12.9%
Net income−0.9%+7.6%+37.3%+13.4%
EPS (diluted)+7.1%+5.5%+13.2%+13.6%

1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.

IQV quarterly EPS vs estimates

Reported EPSAnalyst estimate

IQVIA beat the analyst EPS estimate in 8 of the last 8 quarters. Next report: October 27, 2026 (estimate $2.95).

IQV income statement

IQVIA Holdings Inc. annual income statement
2025202420232022202120202019201820172016
Revenue$16.31B$15.40B$14.98B$14.41B$13.87B$11.36B$11.09B$10.41B$9.70B$6.82B
Cost of revenue$10.88B$10.03B$9.74B$9.38B$9.23B$7.50B$7.30B$6.75B$6.30B$4.75B
Gross profit$5.43B$5.38B$5.24B$5.03B$4.64B$3.86B$3.79B$3.67B$3.40B$2.07B
Research & development———————$0$0$0
Sales, general & admin$2.00B$1.99B$2.05B$2.07B$1.96B$1.79B$1.73B$1.72B$1.60B$1.01B
Total operating expenses$3.25B$3.17B$3.26B$3.23B$3.25B$3.13B$3.01B$2.92B$2.74B$1.49B
Operating income$2.18B$2.20B$1.98B$1.80B$1.39B$731.0M$777.0M$741.0M$719.0M$642.0M
Interest income$684.0M$47.0M$36.0M$403.0M$6.0M$6.0M$9.0M$8.0M$7.0M$4.0M
Interest expense$729.0M$670.0M$672.0M$416.0M$375.0M$416.0M$447.0M$414.0M$346.0M$144.0M
Income before taxes$1.61B$1.67B$1.46B$1.35B$1.13B$380.0M$343.0M$343.0M$304.0M$412.0M
Income taxes$252.0M$296.0M$101.0M$260.0M$163.0M$72.0M$116.0M$59.0M−$987.0M$345.0M
Net income$1.36B$1.37B$1.36B$1.09B$966.0M$279.0M$191.0M$259.0M$1.31B$115.0M
EBITDA$2.94B$3.45B$3.26B$2.91B$2.77B$2.08B$2.00B$1.88B$1.65B$849.0M
EPS (diluted)$11.93$11.14$10.21$10.17$9.03$6.42$6.40$5.55$4.69$3.28
Gross margin33.3%34.9%35.0%34.9%33.5%34.0%34.2%35.2%35.1%30.3%
Operating margin13.4%14.3%13.2%12.5%10.0%6.4%7.0%7.1%7.4%9.4%
Net margin8.3%8.9%9.1%7.6%7.0%2.5%1.7%2.5%13.5%1.7%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in IQV's financial statements (latest annual report filed February 17, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.

IQV financial results

In fiscal year 2025 (ended December 31, 2025), IQVIA reported revenue of $16.3 billion, up 5.9% from the year before. It had net income of $1.4 billion (down 0.9%), a net profit margin of 8.3%. Diluted earnings per share came to $11.93. Over five years revenue grew at an average rate of 7.5% a year.

See the IQV stock overview for the latest quote and news, or the IQV chart for price history and technical indicators.

IQV income statement FAQ

What is IQVIA's annual revenue?

IQVIA reported total revenue of $16.3 billion for fiscal year 2025, which ended on December 31, 2025. That was up 5.9% from $15.4 billion the previous year.

Is IQVIA profitable?

Yes. IQVIA reported net income of $1.4 billion in fiscal 2025, a net profit margin of 8.3%; its operating margin was 13.4%.

What is IQVIA's gross margin?

IQVIA's gross margin was 33.3% in fiscal 2025: for every $100 of revenue, IQVIA kept $33 after the direct cost of its products and services.

How fast is IQVIA growing?

Revenue grew 7.5% a year on average over the last five fiscal years, from $11.4 billion to $16.3 billion.

What are IQVIA's earnings per share?

IQVIA earned $11.93 per diluted share in fiscal 2025, compared with $11.14 a year earlier.

When will IQVIA report its next earnings?

IQVIA is expected to report results for the quarter ending September 30, 2026 on October 27, 2026 before the market opens.

When does IQVIA's fiscal year end?

IQVIA's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on February 17, 2026.

Diagnostics & Research income statements